Renaissance Technologies’s MAIA Biotechnology MAIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$599K Buy
+415,700
New +$552K ﹤0.01% 2535
2024
Q2
Sell
-19,000
Closed -$42K 3784
2024
Q1
$42K Sell
19,000
-92,200
-83% -$138K ﹤0.01% 3506
2023
Q4
$130K Buy
+111,200
New +$179K ﹤0.01% 3240
2023
Q3
Sell
-10,800
Closed -$24K 3920
2023
Q2
$24K Sell
10,800
-9,850
-48% -$26.3K ﹤0.01% 3738
2023
Q1
$71K Buy
+20,650
New +$84.9K ﹤0.01% 3584

Other funds holding MAIA

Renaissance Technologies's MAIA Position: Q2 2026 in Review

Renaissance Technologies opened a new position in MAIA Biotechnology (MAIA) in Q2 2026: 415,700 shares worth $599K. The stake represents ﹤0.01% of the portfolio and ranks #2535 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in MAIA as recently as Q1 2024.

Renaissance Technologies first reported a position in MAIA in Q1 2023 and has held it in 5 quarters since. 36 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Renaissance Technologies held 415,700 shares of MAIA Biotechnology worth $599K as of Q2 2026.
  • MAIA Biotechnology was a new Renaissance Technologies position in Q2 2026.
  • MAIA Biotechnology made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2535 holding.
  • Renaissance Technologies first reported a position in MAIA Biotechnology in Q1 2023 and has held it in 5 quarters since.
  • 36 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.